Companies /Healthcare

Thermo Fisher Scientific Inc

NYSE: TMO Diagnostics & Research

$689.97

▲ $5.08 (+0.74%) today

Markets open · 10:57am ET

24/7 Wall St. View

Price Prediction $770.75 +14.4% Our analysts’ 12-month view: target, optimistic case, and floor. TMO price prediction →

TMO at a Glance

Valuation

Market cap: $253.2B
P/E ratio: 36.1
Dividend yield: 0.06%

Profitability

Revenue (TTM): $47.4B
Profit margin: 14.9%
EPS (TTM): $18.96

Price

52-week range: $435 – $706
24/7 target: $770.75
Street target: $750.92

Headquartered in Waltham, MA Fiscal year ends December NYSE: TMO thermofisher.com

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. (NYSE: TMO) serves science globally with annual revenue exceeding $45 billion. The company enables customers to make the world healthier, cleaner and safer by supporting life sciences research, solving complex analytical challenges, increasing laboratory productivity, improving patient health through diagnostics, and aiding in the development and manufacture of life-changing therapies. Thermo Fisher delivers an extensive combination of innovative technologies, purchasing convenience and pharmaceutical services through its portfolio of brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Gibco, Fisher Scientific, Unity Lab Services, Patheon and PPD. The company operates through four reportable segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. Its product and service offerings span mass spectrometry, electron microscopy, genomic sequencing, proteomics, autoimmune diagnostics, laboratory distribution channels, pharmaceutical contract development and manufacturing, and clinical research services. Updated Oct 21, 2026

Latest Activity

PodcastMad Money w/ Jim CramerJim Cramer · 44 min

Oct 26, 7:15pm ET

Mad Money w/ Jim Cramer 10/26/26

Cramer's bear case: a flood of IPOs and secondaries, $148B raised so far this year, drains the money that funds stocks
Applied Materials down from $739 to $387: buy 25 shares now, add on the pattern, finish in the 200s
Moderna after a parabolic move: let it come in before earnings, no buying parabolic charts
Thermo Fisher CEO on a beat-and-raise, BlackBerry's turnaround, and CrowdStrike cyber worries on deck

The call that matters for holders here is supply: Cramer argues the equity and debt markets are nearly tapped out after Meta, Alphabet and SpaceX raisings, with Anthropic's S1 now in line. He stops short of calling a top while pushing for buybacks and takeovers over further deals, favoring staged buying in Applied Materials and patience on Moderna.

TMOThermo Fisher Scientific

Regular session

Oct 21, 2:20pm ET

$694.59

+4.27%open $666.14

An outsized 4.27% day for a life sciences giant, and it follows this morning's Q3 earnings beat. Keep an eye on whether the bid holds into the close.

TMOThermo Fisher Scientific

Regular session

Oct 21, 10:00am ET

$694.47

+4.25%open $666.14

A 4.25% jump to $694.47 follows this morning's Q3 earnings beat. The question now is whether life-science tools demand holds up past one quarter.

TMOThermo Fisher Scientific

Q3 2026

Oct 21, 6:03am ET

EPS

$6.68

est $6.40+4.3%

Revenue

$12.14B

est $11.95B+1.6%

Demand across life-sciences tools is holding up: Thermo Fisher beat on both lines with adjusted operating margin widening 120 basis points to 24.5%. Updated full-year guidance lands on this morning's call, so keep an eye on the stock.

Quarterly EPS — reported vs estimate

Loading…

TMOThermo Fisher Scientific Inc.

Reports Wed Oct 21Before open6:00 AM ETConfirmed

Oct 21, 5:00am ET

Twelve straight quarters of EPS beats go on the line at 6:00 AM ET, with consensus at $6.40 on $11.95 billion in revenue. The real tell is whether life-science tools and bioprocessing demand held up well enough to extend the run.

TMOThermo Fisher Scientific

Oct 15, 6:00pm ET

New 52-week high$696.49+2.5% vs prior high · 2026-09-29

Thermo Fisher just set a 52-week high at $696.49, roughly 56% above its March low. The $257.6 billion life-science tools name has never been priced higher in the past year.

TMOThermo Fisher Scientific

After-hours

Oct 6, 4:00pm ET

$657.16

-4.05%open $684.91

A 4.05% slide to $657.16 is a heavy day for a $243 billion life sciences bellwether, erasing roughly $10 billion of market value. Keep an eye on whether the stock stabilizes near that level in the next session.

TMOThermo Fisher Scientific

Regular session

Oct 6, 11:00am ET

$656.19

-4.19%open $684.91

A 4.2% slide to $656.19 takes roughly $10 billion off a $242.6 billion life-sciences giant that rarely moves this much in a single session. Watch whether it holds above the open of $684.91 on any bounce attempt.

TMO Coverage

7:51am ET

Investing

Here Are Friday’s Top Wall Street Analyst Research Calls: Deckers Outdoor, Globe Life, Guardant Health, Hess Midstream LP, Kimberly-Clark, Natera, NVR, SpaceX, Thermo Fisher Scientific, and More

Pre-Market Stock Futures: Futures are trading lower as we get to wrap up a busy week, and what a week it has been. After a solid mid-week rally on Wednesday that had…

DECK DIOD FR

Lee Jackson

8:06am ET

Investing

Here Are Tuesday’s Top Wall Street Analyst Research Calls: Abercrombie & Fitch, Affirm Holdings, Eagle Materials, Klarna Group, Martin Marietta Materials, Oklo, Qualcomm, Robinhood Markets, Ulta Beauty, and More

Stocks took a beating Tuesday as surging oil prices and looming inflation data rattled every corner of the market, and now Wall Street analysts are reshuffling their calls on names ranging from…

MLM TMO

Lee Jackson

9:35am ET

Investing

‘Corporate America Is Basically Exterminating Your Career.” Clark Howard’s Sounds Alarm For Americans In Their 50s, Who Want To Work Till 65

Clark Howard named a specific age when corporate America tends to push workers out, and it falls years before most people's retirement plans even begin to account for income gaps, portfolio shortfalls,…

SCHW TMO

AJ Tiarsmith

8:05am ET

Investing

Here Are Thursday’s Top Wall Street Analyst Research Calls: Broadcom, Deere & Company, Dell Technologies, Devon Energy, Moderna, Permian Resources, PG&E, Thermo Fisher, Viper Energy, and More

Markets wobble heading into the Labor Day weekend as bond vigilantes push back against Washington, oil stays tense with Middle East strikes escalating, and Wall Street analysts make bold calls on names…

AVGO CPRT DE

Lee Jackson

10:00am ET

Investing

Agilent Stock Has A Catalyst Coming On August 26 That Investors Should Not Ignore

Agilent Technologies has a company-confirmed earnings report dropping after the close on August 26, and every operating lever heading into that date is pointing the same direction. Here is what retirement-focused investors…

A TMO WAT

Joel South

8:50am ET

Investing

Jefferies Global Best Ideas List Has 5 US Dividend Stocks With Huge Total Return Potential

Jefferies just named five U.S. dividend stocks to its exclusive Global Best Ideas list, and with the S&P 500 stretched to historically expensive valuations, the case for these high-conviction picks has never…

AHR BAC CAT

Lee Jackson

8:04am ET

Investing

Here Are Friday’s Top Wall Street Analyst Research Calls: Brown-Forman, Chord Energy, Emerson Electric, FuboTV, Genmab, Honeywell, Knight-Swift, Wix.Com, and More

Pre-Market Stock Futures: Futures are trading lower as we prepare to end another up-and-down week, and, as we mentioned before, it all depends on the status of the war with Iran and…

AGX BF-B CHRD

Lee Jackson

9:41am ET

Investing

Healthcare Dividend Stocks: The Recession-Proof Income Play for 2026

If a recession were to hit, it’s a foregone conclusion that people won’t stop taking their prescriptions, and they won’t cancel major medical treatments. The same can be said for people who…

AZN GILD MRK

David Beren

8:57am ET

Investing

The Lab Equipment Titan Trading at Half the Multiple Just Delivered Another Beat

Danaher (NYSE: DHR | DHR Price Prediction) and Thermo Fisher Scientific (NYSE: TMO) both reported Q3 2025 earnings showing revenue growth around 5%, but underlying business momentum tells very different stories. Danaher…

DHR TMO

William Temple

11:50am ET

Investing

Cathie Wood Is Dumpster Diving Again With These 3 Stock Buys

The Rise of a Frenzied Trading Style Cathie Wood, founder of ARK Invest, burst into investor consciousness in 2020 when her flagship ARK Innovation ETF (NYSEARCA:ARKK) soared 153%, fueled by bold bets…

ABNB AMZN ARKF

Rich Duprey

8:52am ET

Investing

3 Hedge Fund Favorite Stocks Trading At Yearly Low Prices

With another 13F filing season out of the way, investors may wish to check out the names that the big money has been scooping up in recent months. In the first quarter,…

CVX KHC TMO

Joey Frenette

12:00pm ET

Investing

Billionaire Investor Buys Stocks Despite Trump’s ‘Unconventional Approach’

Daniel Loeb is a brilliant billionaire investor who’s invested in all sorts of market environments. Indeed, this isn’t the first time he’s encountered intense uncertainty and it probably won’t be the last.…

TMO TSLA

Joey Frenette

8:42am ET

Investing

Thursday’s Top Analyst Upgrades and Downgrades: American Airlines, Amgen, Block, Chewy, First Solar, Nvidia, Southwest Airlines and More

Thursday's top analyst upgrades and downgrades included American Airlines, Amgen, Block, Chewy, First Solar, Nvidia, Southwest Airlines, Taiwan Semiconductor Manufacturing and Toast.

AAL AMGN CE

Lee Jackson

8:49am ET

Investing

Thursday’s Top Wall Street Analyst Upgrades and Downgrades: Airbnb, Apple, Cinemark, Cisco, Coinbase, Etsy, Lyft, Microsoft, Redfin, Snowflake, Starbucks and More

Thursday's top analyst upgrades and downgrades included Airbnb, Apple, Bluebird Bio, Cinemark, Cisco Systems, Coinbase Global, Etsy, Lyft, Microsoft, QuantumScape, Redfin, Snowflake and Starbucks.

AAPL ABNB BLUE

Lee Jackson

8:51am ET

Investing

Friday’s Top Analyst Upgrades and Downgrades: Activision Blizzard, Carvana, Coinbase Global, Domino’s Pizza, Goldman Sachs, Meta Platforms, Netflix, Snowflake, Spotify, Uber and More

These are the top analyst upgrades, downgrades, and initiations seen before markets opened on Friday, July 14, 2023.

APA ATVI CCI

Lee Jackson

Frequently Asked Questions

What does Thermo Fisher Scientific do?

Thermo Fisher Scientific Inc. (NYSE: TMO) serves science globally with annual revenue exceeding $45 billion.

What is the TMO stock price target?

24/7 Wall St.'s 12-month price target for TMO is $770.75, rated Buy. The Wall Street consensus target is $750.92. TMO price prediction →